NAcM-OPT

Overview

NAcM-OPT is an orally bioavailable cullin neddylation 1 ( DCN1 ) inhibitor, which potently inhibits the DCN1-UBE2M interaction.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Liver Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > E1/E2/E3 Enzyme | Products > Signaling Pathways > NEDD8-activating Enzyme

Product Information

• Catalog No.: HY-111505
• CAS No.: 2089293-61-6
• Molecular Formula: C23H29Cl2N3O
• Molecular Weight: 434.40
• Purity: 98.69%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.08 mg/mL (4.79 mM); Clear solution
• Availability: In-stock

Source

Original product source